Chemoinformaics analysis of 1alpha,2alpha,3beta,24-Tetrahydroxyolean-12-en-28-oic acid
| Molecular Weight | 504.708 | nRot | 2 |
| Heavy Atom Molecular Weight | 456.324 | nRig | 27 |
| Exact Molecular Weight | 504.345 | nRing | 5 |
| Solubility: LogS | -3.755 | nHRing | 0 |
| Solubility: LogP | 3.747 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 86.9181 |
| nHD | 5 | BPOL | 49.0219 |
| QED | 0.361 |
| Synth | 5.143 |
| Natural Product Likeliness | 3.248 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.015 |
| Pgp-sub | 0.01 |
| HIA | 0.012 |
| CACO-2 | -5.622 |
| MDCK | 0.00000667 |
| BBB | 0.205 |
| PPB | 0.823064 |
| VDSS | 0.472 |
| FU | 0.162011 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.416 |
| CYP2c19-inh | 0.004 |
| CYP2c19-sub | 0.695 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.133 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.078 |
| CYP3a4-inh | 0.256 |
| CYP3a4-sub | 0.111 |
| CL | 2.169 |
| T12 | 0.5 |
| hERG | 0.021 |
| Ames | 0.027 |
| ROA | 0.508 |
| SkinSen | 0.056 |
| Carcinogencity | 0.025 |
| EI | 0.014 |
| Respiratory | 0.975 |
| NR-Aromatase | 0.808 |
| Antiviral | Yes |
| Prediction | 0.573212 |